N-terminal pro-brain natriuretic peptide is associated with a future diagnosis of cancer in patients with coronary artery disease
Author
Tuñón Fernández, José Luis



Entity
UAM. Departamento de Medicina; Instituto de Investigación Sanitaria Fundación Jiménez Díaz (IIS-FJD)Publisher
Public Library of ScienceDate
2015-06-05Citation
10.1371/journal.pone.0126741
PLOS ONE 10.6 (2015); e0126741
ISSN
1932-6203DOI
10.1371/journal.pone.0126741Funded by
This work was supported by grants from Fondo de Investigaciones Sanitarias (PI05/0451, PI05/1497,PI05/2475, PI05/1043, PS09/01405, PI10/ 00072, and PI10/0234, PI14/1567, Programa de Estabilización to LBC); Spanish Society of Cardiology and Spanish Heart Foundation; Spanish Society of Arteriosclerosis; RECAVA (RD06/0014/0035, www. recava.com); Fundación Lilly; and Instituto de Salud Carlos III FEDER (FJD biobank: RD09/0076/00101).Editor's Version
http://dx.doi.org/10.1371/journal.pone.0126741Subjects
Natriuretic peptides; Cancer; Coronary artery disease; MedicinaRights
© 2015 Tuñón et al.Abstract
Objective
Several papers have reported elevated plasma levels of natriuretic peptides in patients with
a previous diagnosis of cancer. We have explored whether N-terminal pro-brain natriuretic
peptide (NT-proBNP) plasma levels predict a future diagnosis of cancer in patients with coronary
artery disease (CAD).
Methods
We studied 699 patients with CAD free of cancer. At baseline, NT-proBNP, galectin-3,
monocyte chemoattractant protein-1, soluble tumor necrosis factor-like weak inducer of apoptosis,
high-sensitivity C-reactive protein, and high-sensitivity cardiac troponin I plasma
levels were assessed. The primary outcome was new cancer diagnosis. The secondary outcome
was cancer diagnosis, heart failure requiring hospitalization, or death.
Results
After 2.15±0.98 years of follow-up, 24 patients developed cancer. They were older (68.5
[61.5, 75.8] vs 60.0 [52.0, 72.0] years; p=0.011), had higher NT-proBNP (302.0 [134.8,
919.8] vs 165.5 [87.4, 407.5] pg/ml; p=0.040) and high-sensitivity C-reactive protein (3.27
[1.33, 5.94] vs 1.92 [0.83, 4.00] mg/L; p=0.030), and lower triglyceride (92.5 [70.5, 132.8] vs
112.0 [82.0, 157.0] mg/dl; p=0.044) plasma levels than those without cancer. NT-proBNP
(Hazard Ratio [HR]=1.030; 95% Confidence Interval [CI]=1.008-1.053; p=0.007) and
triglyceride levels (HR=0.987; 95%CI=0.975-0.998; p=0.024) were independent predictors
of a new cancer diagnosis (multivariate Cox regression analysis). When patients in
whom the suspicion of cancer appeared in the first one-hundred days after blood extraction
were excluded, NT-proBNP was the only predictor of cancer (HR=1.061; 95%
CI=1.034-1.088; p<0.001). NT-proBNP was an independent predictor of cancer, heart failure,
or death (HR=1.038; 95%CI=1.023-1.052; p<0.001) along with age, and use of insulin
and acenocumarol.
Conclusions
NT-proBNP is an independent predictor of malignancies in patients with CAD. New studies
in large populations are needed to confirm these findings
Files in this item
Google Scholar:Tuñón Fernández, José Luis
-
Higueras, Javier
-
Tarín, Nieves
-
Cristóbal, Carmen
-
Lorenzo González, Óscar
-
Blanco-Colio, Luis
-
Martín Ventura, José Luis
-
Huelmos, Ana
-
Alonso, Joaquín
-
Aceña Navarro, Álvaro
-
Pello, Ana María
-
Carda, Rocío
-
Asensio, Dolores
-
Mahillo, Ignacio
-
López Bescós, Lorenzo
-
Egido, Jesús
-
Farré, Jerónimo
This item appears in the following Collection(s)
Related items
Showing items related by title, author, creator and subject.
-
Impact of plasma pro-B-type natriuretic peptide amino-terminal and galectin-3 levels on the predictive capacity of the LIPID Clinical Risk Scale instable coronary disease
Higueras, Javier; Martín Ventura, José Luis; Blanco-Colio, Luis; Cristóbal, Carmen; Tarín, Nieves; Huelmos, Ana; Alonso, Joaquín; Pello, Ana María; Aceña Navarro, Álvaro
; Carda, Rocío; Lorenzo González, Óscar
; Mahillo, Ignacio; Asensio, Dolores; Almeida, Pedro; Rodríguez Artalejo, Fernando
; Farré, Jerónimo; López Bescós, Lorenzo; Egido, Jesús; Tuñón Fernández, José Luis
2015-03-01 -
Parathormone levels add prognostic ability to N-terminal pro-brain natriuretic peptide in stable coronary patients
Gutiérrez-Landaluce, Carlos; Aceña Navarro, Álvaro; Pello, Ana; Martínez-Milla, Juan; González-Lorenzo, Óscar; Tarín, Nieves; Cristóbal, Carmen; Blanco-Colio, Luis M.; Martín Ventura, José Luis
; Huelmos, Ana; López-Castillo, Marta; Alonso, Joaquín; López Bescós, Lorenzo; Alonso-Pulpón, Luis; González-Parra, Emilio; Egido, Jesús; Mahíllo-Fernández, Ignacio; Lorenzo González, Óscar
; González-Casaus, María Luisa; Tuñón Fernández, José Luis
2021-05-01 -
Differential profile in inflammatory and mineral metabolism biomarkers in patients with ischemic heart disease without classical coronary risk factors
Pello, Ana María; Cristóbal, Carmen; Tarín, Nieves; Huelmos, Ana; Aceña Navarro, Álvaro; Carda, Rocío; González-Casaus, María Luisa; Alonso, Joaquín; Lorenzo González, Óscar
; Blanco-Colio, Luis; Martín Ventura, José Luis
; Franco Peláez, Juan Antonio; Mahillo, Ignacio; Farré, Jerónimo; López-Bescós, Lorenzo; Egido, Jesús; Tuñón Fernández, José Luis
2016-01-01